RU2012129259A - DIAGNOSTIC METHOD FOR LUNG CANCER - Google Patents
DIAGNOSTIC METHOD FOR LUNG CANCER Download PDFInfo
- Publication number
- RU2012129259A RU2012129259A RU2012129259/10A RU2012129259A RU2012129259A RU 2012129259 A RU2012129259 A RU 2012129259A RU 2012129259/10 A RU2012129259/10 A RU 2012129259/10A RU 2012129259 A RU2012129259 A RU 2012129259A RU 2012129259 A RU2012129259 A RU 2012129259A
- Authority
- RU
- Russia
- Prior art keywords
- cancer
- aptamers
- blood
- selection
- lung cancer
- Prior art date
Links
Abstract
1. Способ диагностики рака легкого человека, включающий подбор в процессе селекции аптамеров к опухолевым тканям легкого человека и использование этих аптамеров для распознавания рака, отличающийся тем, что белки, специфичные для опухолевой ткани выявляют из сыворотки крови больного, инкубированной с аптамерами, полученными в результате их селекции к разным гистологическим типам рака легкого, с использованием в качестве негативных мишеней здоровой ткани легкого и крови здорового человека, а также крови больных воспалением легких и крови больных другими формами онкопатологий (рак молочной железы, рак почек и рак печени).2. Способ диагностики рака легкого человека по п.1, отличающийся тем, что сыворотку крови больного инкубируют с аптамерами, связанными с биотином, и магнитными частицами, связанными со стрептавидином с последующей концентрацией белковых комплексов на стенке пробирки с помощью магнита, инкубацией с аптамерами, мечеными флуоресцентной меткой и исследовании полученного образца на наличие флуоресцентной метки.1. A method for the diagnosis of human lung cancer, including the selection in the process of selection of aptamers to the tumor tissues of the human lung and the use of these aptamers for cancer recognition, characterized in that proteins specific for the tumor tissue are detected from the patient’s blood serum incubated with the aptamers obtained as a result their selection for different histological types of lung cancer, using healthy lung tissue and blood of a healthy person, as well as blood of patients with pneumonia and blood as negative targets and other forms of cancer pathology of patients (breast cancer, renal cancer, and liver cancer) .2. A method for diagnosing human lung cancer according to claim 1, characterized in that the patient's blood serum is incubated with aptamers associated with biotin and magnetic particles associated with streptavidin, followed by concentration of protein complexes on the tube wall using a magnet, incubation with aptamers labeled with fluorescent labeling and examining the obtained sample for the presence of a fluorescent label.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012129259/10A RU2012129259A (en) | 2012-07-10 | 2012-07-10 | DIAGNOSTIC METHOD FOR LUNG CANCER |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012129259/10A RU2012129259A (en) | 2012-07-10 | 2012-07-10 | DIAGNOSTIC METHOD FOR LUNG CANCER |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2012129259A true RU2012129259A (en) | 2014-01-20 |
Family
ID=49944881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012129259/10A RU2012129259A (en) | 2012-07-10 | 2012-07-10 | DIAGNOSTIC METHOD FOR LUNG CANCER |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2012129259A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106353499A (en) * | 2016-09-14 | 2017-01-25 | 燕山大学 | Kit for detecting lung cancer serum marker aptamer and gene at same time and application thereof |
-
2012
- 2012-07-10 RU RU2012129259/10A patent/RU2012129259A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106353499A (en) * | 2016-09-14 | 2017-01-25 | 燕山大学 | Kit for detecting lung cancer serum marker aptamer and gene at same time and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009003562A (en) | Elisa for vegf. | |
CN103031276A (en) | Method for obtaining circulating tumor single-cell | |
CN103725648A (en) | Novel CTC (circulating tumor cell) enrichment technology and preparation method of kit | |
CN104316685A (en) | Diacetyl spermine detection kit and preparation method and application thereof | |
EA201590686A1 (en) | TEST ON MITOCHONDRIAL TOXICITY | |
EA201170365A1 (en) | METHOD AND DEVICE FOR DIAGNOSTICS AND SCREENING OF DISEASES WITH USE OF ELECTROMAGNETIC FIELDS OF SUPERLINE FREQUENCY | |
RU2012129259A (en) | DIAGNOSTIC METHOD FOR LUNG CANCER | |
RU2444015C1 (en) | Differential diagnostic technique for pneumonia and infiltrative pulmonary tuberculosis | |
CN103432585A (en) | Targeted marking system for efficiently mediating folate receptor-alpha subtype | |
Armstrong | Epithelial-mesenchymal transition in cancer progression | |
Hudiță et al. | Optimization of a flow cytometry method for the approach of liquid biopsy as a therapy modulation tool in patients with colorectal cancer | |
RU2010143359A (en) | METHOD FOR DIFFERENTIAL DIAGNOSTICS OF SKIN DISEASES | |
CN107502650A (en) | A kind of blood in vitro culture antineoplastic susceptibility detection method | |
CN102749453A (en) | Applications of retinoic acid induced protein 16 (RAI16) as hepatocellular carcinoma marker | |
EA201992217A1 (en) | PROTEIN MARKER FOR DIAGNOSTIC OF PROSTATE CANCER, METHOD FOR MEASURING THE NUMBER OF MARKER AND ALGORITHM FOR INTERPRETING THE RESULT | |
CN108982855A (en) | 15- lipoxygenase metabolin is preparing the application in pulmonary cancer diagnosis kit | |
CN104945506A (en) | Immunohistochemical reagent for mammary cancer diagnosis and prognosis judgment | |
CN104945496A (en) | Polypeptide and application thereof in preparing and purifying EHD2-specific antibody | |
CN103344768A (en) | Ischemic heart disease detection kit and application thereof | |
RU2535076C1 (en) | Method of qualitative differential express-diagnostics of lip mucosa neoplasms by content of biomarkers in patient's oral fluid | |
CN102520174A (en) | Method related to detection of lung cancer by using lung cancer diagnostic reagent kit | |
Remitha et al. | P17-9 Absolute white blood cell counts profile as metastatic predictive factors in premenopausal breast cancer | |
US20220196648A1 (en) | Polypeptide magnetic nanoparticle, preparation method therefor and use thereof | |
Kuzmenko et al. | Innovative analysis of blood | |
Vynnychenko et al. | PROSPECTS FOR THE APPLICATION OF THE MOST MODERN METHODS OF DIAGNOSIS OF LUNG CANCER |